Bloomberg @business
Zantac was taken off the shelves in 2020 over links to cancer. A Businessweek investigation has uncovered hundreds of documents that show how the drug’s maker kept quiet about those risks for 40 years https://t.co/8QJ1O5VPRk — PolitiTweet.org